MASSACHUSETTS GENERAL HOSPITAL
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1811-01-01
- Employees
- -
- Market Cap
- -
A Prospective, Randomized Trial of the Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms
Phase 4
- Conditions
- Opioid-use DisorderOpioid Use Disorder, Mild
- Interventions
- First Posted Date
- 2019-09-16
- Last Posted Date
- 2019-09-16
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 76
- Registration Number
- NCT04091009
Denosumab to Prevent High-Turnover Bone Loss After Bariatric Surgery
Phase 4
Completed
- Conditions
- Bariatric Surgery CandidateBone Loss
- Interventions
- First Posted Date
- 2019-09-12
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 36
- Registration Number
- NCT04087096
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸University of California, San Francisco, San Francisco, California, United States
Early Insertion of Axillary Impella® With VA ECMO
Not Applicable
Terminated
- Conditions
- Cardiogenic Shock
- Interventions
- Device: Axillary Impella®
- First Posted Date
- 2019-09-10
- Last Posted Date
- 2021-06-29
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 2
- Registration Number
- NCT04084015
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Piloting Text Messages to Promote Positive Affect and Physical Activity
Not Applicable
Completed
- Conditions
- Acute Coronary Syndrome
- First Posted Date
- 2019-09-04
- Last Posted Date
- 2020-02-21
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 63
- Registration Number
- NCT04077229
- Locations
- 🇺🇸
Jeff Huffman, Boston, Massachusetts, United States
EEG Monitoring in the Emergency Department
Active, not recruiting
- Conditions
- Substance AbuseDrug OverdoseAlcohol Abuse
- Interventions
- Other: Observational EEG Monitoring
- First Posted Date
- 2019-08-28
- Last Posted Date
- 2023-08-01
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT04070521
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Treating Depression in Patients With De Quervain's Tenosynovitis; An Integrated Web Based Skills Intervention
Not Applicable
Terminated
- Conditions
- De Quervain Disease
- Interventions
- Other: Decision AidBehavioral: Toolkit for de Quervain's
- First Posted Date
- 2019-08-28
- Last Posted Date
- 2022-05-05
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 22
- Registration Number
- NCT04069741
- Locations
- 🇺🇸
Hand and Arm Center, Massachusetts General Hospital, Boston, Massachusetts, United States
Population Effectiveness of Dolutegravir Implementation in Sub-Saharan Africa
Completed
- Conditions
- HIV-1-infection
- Interventions
- Other: This is an observational study only.
- First Posted Date
- 2019-08-22
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 1000
- Registration Number
- NCT04066036
- Locations
- 🇿🇦
Africa Health Research Institute, Somkele, KwaZulu-Natal, South Africa
🇺🇬Mbarara University of Science and Technology, Mbarara, Uganda
Wireless Physiologic Monitoring in Postpartum Women
Not Applicable
- Conditions
- Maternal Death During ChildbirthPregnancy Complications
- Interventions
- Combination Product: Wireless physiologic monitoring
- First Posted Date
- 2019-08-19
- Last Posted Date
- 2020-09-10
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 2462
- Registration Number
- NCT04060667
- Locations
- 🇺🇬
Mbarara Regional Referral Hospital, Mbarara, Uganda
Mechanism of Action of Electroconvulsive Therapy
Recruiting
- Conditions
- Unipolar DepressionBipolar Depression
- Interventions
- Device: Electroconvulsive Therapy
- First Posted Date
- 2019-08-16
- Last Posted Date
- 2024-03-22
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 136
- Registration Number
- NCT04059952
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
AMD3100 Plus Pembrolizumab in Immune Checkpoint Blockade Refractory Head and Neck Squamous Cell Carcinoma
- First Posted Date
- 2019-08-15
- Last Posted Date
- 2020-09-07
- Lead Sponsor
- Massachusetts General Hospital
- Registration Number
- NCT04058145
- Locations
- 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath